Market Research Logo

Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) – Global Forecast to 2023

Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) – Global Forecast to 2023

“The transplant diagnostics market projected to grow at a CAGR of 7.4%.”
The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%. Increasing number of transplantation procedures, technological advancements in the field of transplant diagnostics, increasing public-private funding for target research activities, and growing burden of infectious diseases are some of the factors responsible for the growth of this market. However, high procedural cost for next-generation sequencing (NGS) and PCR-based diagnostics assays and limited availability of reimbursements for target procedures are expected to limit the optimal adoption of transplant diagnostics during the forecast period.

“The molecular assay technologies segment is poised to be the fastest-growing during the forecast period.”
On the basis of technology, the transplant diagnostics market is segmented into molecular (PCR based assay and sequencing based assay technologies) and non-molecular assays. The molecular assay technology segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the technological benefits of molecular assays such as low turnaround time, high procedural efficacy, study of multiple samples, and real-time sample analysis.

“Asia Pacific is expected to register the highest growth rate during the forecast period.”
Geographically, the transplant diagnostics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The highest CAGR for the APAC transplant diagnostics market can be attributed to the increasing adoption of cutting-edge diagnostic technologies among medical professionals, rapid rise in geriatric population (especially in Japan and China), and universal government healthcare coverage in Japan (including for transplantation & related diagnostic procedures).

Breakdown of supply-side primary interviews: by company type, designation, and region:
By Company Type - Tier 1 - 25%, Tier 2 - 30% and Tier 3 - 45%
By Designation - C-level - 26%, Director-level - 30%, Others - 44%
By Region - North America - 34%, Europe - 26%, APAC - 23%, RoW - 17%

The global transplant diagnostics market is competitive, with a large number of global and local players. In 2017, the market was dominated by Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and Immucor, Inc. (US). Product launches, market expansions, strategic acquisitions, and partnerships, agreements, & collaborations were the major strategies adopted by market players to achieve growth in the market.

Research Coverage
This report studies the transplant diagnostics market based on technology, product, transplant type, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the transplant diagnostics market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on product portfolios offered by the major players in the transplant diagnostics market. The report analyzes the transplant diagnostics market based on technology, product, transplant type, application, end user, and region
Product Development: Detailed insights on the research and development activities and product launches in the transplant diagnostics market
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various transplant diagnostics across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the transplant diagnostics market
Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the transplant diagnostics market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • GEOGRAPHIC SCOPE
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY USED FOR THE STUDY
    • MAJOR MARKET STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • PRODUCT-BASED MARKET ESTIMATION
      • PROCEDURE BASED MARKET ESTIMATION
      • PRIMARY RESEARCH VALIDATION
    • DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS
    • RESEARCH LIMITATIONS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • TRANSPLANT DIAGNOSTICS MARKET OVERVIEW
    • TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY
    • REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION
    • ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2018
    • REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
    • REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE
    • TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • KEY MARKET DRIVERS
        • Table PUBLIC-PRIVATE INVESTMENTS AND RESEARCH GRANTS FOR THE DEVELOPMENT OF TRANSPLANT DIAGNOSTIC PRODUCTS, 2015-2018
      • KEY MARKET RESTRAINTS
        • Table COST OF ASSAYS FOR MAJOR NGS/PCR-BASED GENOMIC TESTS IN EUROPE (AS OF 2014)
        • Table MEDICAL REIMBURSEMENTS FOR TRANSPLANTATION PROCEDURES IN THE US (2017)
      • KEY MARKET OPPORTUNITIES
      • KEY MARKET CHALLENGES
  • TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES
    • INTRODUCTION
      • Table TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2016-2023 (USD MILLION)
    • REAGENTS AND CONSUMABLES
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2016-2023 (USD MILLION)
    • INSTRUMENTS
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2016-2023 (USD MILLION)
    • SOFTWARE AND SERVICES
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2016-2023 (USD MILLION)
  • TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
    • MOLECULAR ASSAYS
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR MOLECULAR ASSAYS, BY REGION, 2016-2023 (USD MILLION)
      • PCR-BASED MOLECULAR ASSAYS
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY PRODUCT, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY END USER, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY REGION, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR REAL-TIME PCR, BY REGION, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCE-SPECIFIC PRIMER-PCR, BY REGION, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCE-SPECIFIC OLIGONUCLEOTIDE-PCR, BY REGION, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR OTHER PCR-BASED MOLECULAR ASSAYS, BY REGION, 2016-2023 (USD MILLION)
      • SEQUENCING-BASED MOLECULAR ASSAYS
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY PRODUCT, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY END USER, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY REGION, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR SANGER SEQUENCING, BY REGION, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR OTHER SEQUENCING MOLECULAR ASSAYS, BY REGION, 2016-2023 (USD MILLION)
    • NON-MOLECULAR ASSAYS
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAYS, BY PRODUCT, 2016-2023 (USD MILLION)
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAYS, BY APPLICATION, 2016-2023 (USD MILLION)
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAYS, BY END USER, 2016-2023 (USD MILLION)
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAYS, BY REGION, 2016-2023 (USD MILLION)
  • TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE
    • INTRODUCTION
      • Table TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2016-2023 (USD MILLION)
    • SOLID ORGAN TRANSPLANT
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR SOLID ORGAN TRANSPLANT, BY TYPE, 2016-2023 (USD MILLION)
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR SOLID ORGAN TRANSPLANT, BY REGION, 2016-2023 (USD MILLION)
      • KIDNEY TRANSPLANT
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR KIDNEY TRANSPLANT, BY REGION, 2016-2023 (USD MILLION)
      • LIVER TRANSPLANT
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR LIVER TRANSPLANT, BY REGION, 2016-2023 (USD MILLION)
      • HEART TRANSPLANT
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR HEART TRANSPLANT, BY REGION, 2016-2023 (USD MILLION)
      • LUNG TRANSPLANT
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR LUNG TRANSPLANT, BY REGION, 2016-2023 (USD MILLION)
      • PANCREAS TRANSPLANT
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR PANCREAS TRANSPLANT, BY REGION, 2016-2023 (USD MILLION)
      • OTHER ORGAN TRANSPLANTATIONS
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR OTHER ORGAN TRANSPLANT, BY REGION, 2016-2023 (USD MILLION)
    • STEM CELL TRANSPLANT
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR STEM CELL TRANSPLANT, BY REGION, 2016-2023 (USD MILLION)
    • SOFT TISSUE TRANSPLANT
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR SOFT TISSUE TRANSPLANT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
    • DIAGNOSTIC APPLICATIONS
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2016-2023 (USD MILLION)
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
      • PRE-TRANSPLANTATION DIAGNOSTICS
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR PRE-TRANSPLANTATION DIAGNOSTICS, BY TYPE, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR PRE-TRANSPLANTATION DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR HISTOCOMPATIBILITY TESTING, BY REGION, 2016-2023 (USD MILLION)
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR BLOOD PROFILING, BY REGION, 2016-2023 (USD MILLION)
      • POST-TRANSPLANTATION DIAGNOSTICS
        • Table TRANSPLANT DIAGNOSTICS MARKET FOR POST-TRANSPLANTATION DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
    • RESEARCH APPLICATIONS
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TRANSPLANT DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
    • INDEPENDENT REFERENCE LABORATORIES
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2016-2023 (USD MILLION)
    • HOSPITALS & TRANSPLANT CENTERS
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR HOSPITALS & TRANSPLANT CENTERS, BY REGION, 2016-2023 (USD MILLION)
    • RESEARCH LABORATORIES & ACADEMIC INSTITUTES
      • Table TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2016-2023 (USD MILLION)
  • TRANSPLANT DIAGNOSTICS MARKET, BY REGION
    • INTRODUCTION
      • Table TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table TOTAL NUMBER OF SOLID ORGAN TRANSPLANTATIONS ACROSS KEY COUNTRIES (2016)
    • NORTH AMERICA
      • Table NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • US
        • Table US: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table US: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
        • Table US: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • CANADA
        • Table CANADA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table CANADA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
        • Table CANADA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
    • EUROPE
      • Table EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table EUROPE: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • Table EUROPE: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • Table EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2016-2023 (USD MILLION)
      • Table EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
      • Table EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2016-2023 (USD MILLION)
      • Table EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • GERMANY
        • Table GERMANY: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table GERMANY: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
        • Table GERMANY: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • UK
        • Table ORGAN TRANSPLANTATIONS PERFORMED IN THE UK, 2013 VS. 2015
        • Table UK: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table UK: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
        • Table UK: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • FRANCE
        • Table FRANCE: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table FRANCE: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
        • Table FRANCE: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table ROE: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
        • Table ROE: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • JAPAN
        • Table JAPAN: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table JAPAN: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
        • Table JAPAN: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • CHINA
        • Table ORGAN TRANSPLANTATIONS PERFORMED IN CHINA, 2013 VS. 2015
        • Table CHINA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table CHINA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
        • Table CHINA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • INDIA
        • Table INDIA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table INDIA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
        • Table INDIA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table SOLID-ORGAN TRANSPLANTATIONS PERFORMED IN THE ROAPAC, 2013 VS. 2016
        • Table ROAPAC: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table ROAPAC: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
        • Table ROAPAC: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table ROW: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • Table ROW: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
      • Table ROW: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2016-2023 (USD MILLION)
      • Table ROW: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
      • Table ROW: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2016-2023 (USD MILLION)
      • Table ROW: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SCENARIO
      • KEY PRODUCT LAUNCHES AND ENHANCEMENTS (2014 TO 2018)
      • KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2014 TO 2018)
      • MAJOR ACQUISITIONS (2014 TO 2018)
      • KEY EXPANSIONS (2014 TO 2018)
  • COMPANY PROFILES
    • INTRODUCTION
      • GEOGRAPHIC BENCHMARKING
    • BECTON, DICKINSON AND COMPANY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2014-2018)
      • MNM VIEW
    • BIOFORTUNA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2014-2018)
      • MNM VIEW
    • BIOMÉRIEUX SA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2014-2018)
      • MNM VIEW
    • BIO-RAD LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2014-2018)
      • MNM VIEW
    • CAREDX
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2014-2018)
      • MNM VIEW
    • F. HOFFMAN-LA ROCHE LIMITED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2018)
      • MNM VIEW
    • GENDX
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES OFFERED
      • RECENT DEVELOPMENTS (2014-2018)
      • MNM VIEW
    • HOLOGIC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2014-2018)
      • MNM VIEW
    • ILLUMINA
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES OFFERED
      • RECENT DEVELOPMENTS (2013-2018)
      • MNM VIEW
    • IMMUCOR
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2014-2018)
      • MNM VIEW
    • LUMINEX
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2014-2018)
      • MNM VIEW
    • MERCK KGAA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • OMIXON
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2014-2018)
      • MNM VIEW
    • QIAGEN
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2014-2018)
      • MNM VIEW
    • THERMO FISHER SCIENTIFIC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2014-2018)
      • MNM VIEW
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report